![Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA](https://primarycareipa.org/wp-content/uploads/2020/11/pt-chart1.38_1.jpg)
Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline | Primary Care IPA
![CURRENT ANTIDIABETIC DRUGS AND STRATEGIES FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS | Semantic Scholar CURRENT ANTIDIABETIC DRUGS AND STRATEGIES FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c437fa30292accc4b8c1ee3eb226eb30fc27a4ed/5-Table2-1.png)
CURRENT ANTIDIABETIC DRUGS AND STRATEGIES FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS | Semantic Scholar
![Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK279141/bin/pharmaco-agent-diab2-Image002.jpg)